Advancing Regulatory Science through Novel Biomarker Research and Science-Based Technologies
The summary for the Advancing Regulatory Science through Novel Biomarker Research and Science-Based Technologies grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Food and Drug Administration, which is the U.S. government agency offering this grant.
Advancing Regulatory Science through Novel Biomarker Research and Science-Based Technologies: As a key component of FDA's Advancing Regulatory Science Initiative, the Office of Critical Path Programs (OCPP) supports innovation in the development, evaluation, and manufacture of new safe and effective medical/veterinary products for diagnosing, treating, and preventing diseases. This Funding Opportunity Announcement (FOA) invites applications that propose applying novel technologies and approaches to developing new biomarkers for well defined human or veterinary diseases and toxicity in areas where an unmet need exists, particularly where such biomarkers show substantial promise to enable or speed product development and evaluation or improve patient effectiveness and healthcare outcomes as well as ensure product availability to patients in a timely manner.Applications should address the Critical Path Initiative mission to facilitate the development of new safe and effective products for diagnosing, treating, and preventing disease.
Federal Grant Title: | Advancing Regulatory Science through Novel Biomarker Research and Science-Based Technologies |
Federal Agency Name: | Food and Drug Administration |
Grant Categories: | Health Science and Technology |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-FD-11-016 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.103 |
CFDA Descriptions: | Food and Drug Administration_Research |
Current Application Deadline: | Jun 16, 2011 |
Original Application Deadline: | Jun 16, 2011 |
Posted Date: | May 03, 2011 |
Creation Date: | May 05, 2011 |
Archive Date: | Jul 16, 2011 |
Total Program Funding: | $1,000,000 |
Maximum Federal Grant Award: | $350,000 |
Minimum Federal Grant Award: | $250,000 |
Expected Number of Awards: | 20 |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education
- Additional Information on Eligibility
- PLEASE NOTE: The synopsis is being revised to reflect a change in eligibility requirements as follows: The entities eligible to enter into partnerships with FDA are governed by Section 566 of the FD&C [21 U.S.C. 360bbb-5". Higher Education Institutions as defined in Section 101 of the Higher Education Act of 1965(or a consortium of such institutions). An eligible organization that wishes to enter into a collaborative agreement must provide an assurance that the entity will not accept funding for a Critical Path Public-Private Partnership project from any organization that manufactures or distributes products regulated by the Food and Drug Administration unless the entity provides assurances in its agreement with the Food and Drug Administration that the results of the Critical Path Public-Private Partnership project will not be influenced by and source of funding.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- gladys Bohler Grants Management Officer/Specialist Phone 301-827-7175
FDA work e-mail [[email protected]] - Similar Government Grants
- • Development and Maintenance of the Animal Food Regulatory Program Standards (U19) Clinical...
- • Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biologic...
- • Cooperative Agreement to Support the World Trade Organization's (WTO) Standards and Trade ...
- • Cooperative Agreement for Long Term Data Collection on Antimicrobial Use in Animals (U01) ...
- • Alliance to Support the Activities of the Integrated Food Safety System (IFSS), including ...
- • Support for Small Scientific Conference Grant Program
- • Cooperative Agreement to Support the World Health Organization (WHO) International Program...
- • Clinical Studies of Safety and Effectiveness of Orphan Products
- More Grants from the Food and Drug Administration
- • Development and Maintenance of the Animal Food Regulatory Program Standards (U19) Clinical...
- • Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biologic...
- • Cooperative Agreement to Support the World Trade Organization's (WTO) Standards and Trade ...